ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke

This study has been terminated.
Study NCT00073476.   Last updated on June 20, 2006.   Information provided by Pfizer
Please refer to this study by its ClinicalTrials.gov identifier: NCT00073476


Locations
United States, California
Pfizer Investigational Site    
      La Mesa, California, United States, 91942
United States, Georgia
Pfizer Investigational Site    
      Atlanta, Georgia, United States, 30342
United States, Indiana
Pfizer Investigational Site    
      Fort Wayne, Indiana, United States, 46804
Pfizer Investigational Site    
      Fort Wayne, Indiana, United States, 46805
United States, Kentucky
Pfizer Investigational Site    
      Louisville, Kentucky, United States, 40202
Pfizer Investigational Site    
      Louisville,, Kentucky, United States, 40202
United States, North Carolina
Pfizer Investigational Site    
      Salisbury, North Carolina, United States, 28144
United States, Ohio
Pfizer Investigational Site    
      Dayton, Ohio, United States, 45408
Pfizer Investigational Site    
      Dayton, Ohio, United States, 45409
Pfizer Investigational Site    
      Dayton, Ohio, United States, 45415
Pfizer Investigational Site    
      DAYTON, Ohio, United States, 45406
United States, Pennsylvania
Pfizer Investigational Site    
      Philadelphia, Pennsylvania, United States, 19141
Pfizer Investigational Site    
      Allentown, Pennsylvania, United States, 18103
Estonia
Pfizer Investigational Site    
      Tartu, Estonia, 51014
Germany
Pfizer Investigational Site    
      Leipzig, Germany, 04103
Pfizer Investigational Site    
      Bad Neustadt, Germany, 97616
Pfizer Investigational Site    
      Freiburg, Germany, 79106
Pfizer Investigational Site    
      Luebeck, Germany, 23538
Hungary
Pfizer Investigational Site    
      BUDAPEST, Hungary, H-1021
Pfizer Investigational Site    
      GYOR, Hungary, H-9023
Italy
Pfizer Investigational Site    
      Perugia, Italy, 06126
Pfizer Investigational Site    
      Pavia, Italy, 27100
Portugal
Pfizer Investigational Site    
      Lisboa, Portugal, 1600
Pfizer Investigational Site    
      Coimbra, Portugal, Codex 3049
Singapore
Pfizer Investigational Site    
      SINGAPORE, Singapore, 169608
Pfizer Investigational Site    
      Singapore, Singapore, 308433
Spain
Pfizer Investigational Site    
      Madrid, Spain, 28007
Pfizer Investigational Site    
      Zaragoza, Spain, 50009
Pfizer Investigational Site    
      Madrid, Spain, 28034
Spain, GALICIA
Pfizer Investigational Site    
      Santiago de Compostela, GALICIA, Spain, 15706

Sponsors and Collaborators
Pfizer

Investigators
Study Director:     Pfizer CT.gov Call Center     Pfizer    





Links to all studies - primarily for crawlers